Abstract
SB5 (Imraldi((R))) is a biosimilar of the reference anti-TNF monoclonal antibody adalimumab. It is approved for use in the following indications for w......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
